Alembic Pharma Share Price: Profit **29%** badha, par margin ki 'tightness'! Kya karein investors?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Alembic Pharma Share Price: Profit **29%** badha, par margin ki 'tightness'! Kya karein investors?
Overview

Alembic Pharma ke investors ke liye mix khabar hai. Company ne Q4 mein profit **29%** bhadaya hai, par operating margins thoda tight ho gaye hain.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Alembic Pharma ne Q4 FY26 mein kamaal kar diya, consolidated net profit 29% badh kar ₹202 crore ho gaya! Revenue bhi 4.4% upar gaya ₹1,848 crore tak. Investors ke liye ye ek aachi khabar thi.

Lekin, jahan profit bada, wahi company ki operating profitability mein thodi dikkat dikhi. EBITDA 16.2% gir kar ₹228 crore raha, aur margin 12.3% par aa gaya, jo pichle saal issi quarter mein 15.4% tha. Iska matlab hai ki expenses revenue se zyada tezi se badh rahe hain.

Is revenue growth mein US formulations ka bada role hai, jo 11% badh kar ₹564 crore ho gaya. Domestic branded business ne bhi ₹568 crore ka contribution diya.

Sabse bada aur interesting play yeh hai ki Alembic Pharma ab US ke branded market mein entry maar raha hai. Unhone 'Pivya' naam ka ek antibiotic launch kiya hai, jo urinary tract infections ke liye hai. Ye US market 2035 tak USD 4.1 billion tak ja sakta hai, aur company issi high-value segment mein apna future bana rahi hai.

Is news ke baad stock reaction thoda negative raha, share price 0.55% gir kar ₹782.10 par band hua. Par market analysts abhi bhi is stock par bullish hain. Unka consensus 'Buy' rating hai aur average target price ₹940-₹970 tak ka hai. Unko lagta hai ki US branded segment mein company ka successful growth future mein badi value create kar sakta hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.